Trial Design Webinars

  1. Linking Study Quality To Leading Practices For Proactive Planning

    How building in quality can lead to transformational process changes.

  2. Moving Beyond Regulatory And Performance Metrics In Starting Clinical Trials

    How sponsors/CROs are looking for ways to incorporate BI into the eClinical systems they are using to empower oversight - turning raw trail data into actionable information.

  3. Moving The Needle Forward On MS Research

    Discover insights from the experts at a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases, about the first clinical efficacy study of GNbAC1, a promising new approach for the treatment of MS.

  4. DIA Now Product Demonstration

    A video overview of the valuable content that can be accessed as a DIA NOW user.

  5. Protein Therapeutics By Immunoaffinity LC-MS: Latest Trends And Recommendations

    Learn about the application of immunoaffinity LC-MS to regulated bioanalysis of biotherapeutics.

  6. Addressing Acceptable Recruitment Methods For Clinical Trial Sponsors And Sites

    Patient engagement solutions to expedite study recruitment.

  7. Leverage An Asia-Pacific Network To Create Regional Efficiencies In Clinical Supply Management

    Clinical packaging, logistics and import/export considerations that should be taken into account when developing a clinical supply strategy in China, Singapore and Japan.

  8. Navigating Clinical Supply Challenges In Emerging Regions

    Don't let the complex logistics involved in the handling of clinical supplies in certain regions of the world put your patients at risk or jeopardize both the study budget and timeline.

  9. Demand Led Services and Clinical Supply Efficiency

    See how this service can benefit you with shorter lead time, less waste, less stock out risk and no booklet labels.

  10. Planning And Conducting Trials Of The Latest Immunotherapies

    In this webinar, INC Research/inVentiv Health experts discuss the factors that sponsors must take into account as they design and execute clinical trials in this space, beginning with a review of the immunotherapy landscape.